704 related articles for article (PubMed ID: 16039941)
1. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan.
Tseng CH; Huang YK; Huang YL; Chung CJ; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2005 Aug; 206(3):299-308. PubMed ID: 16039941
[TBL] [Abstract][Full Text] [Related]
2. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ
Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952
[TBL] [Abstract][Full Text] [Related]
3. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan.
Huang YK; Tseng CH; Huang YL; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):135-42. PubMed ID: 17173945
[TBL] [Abstract][Full Text] [Related]
4. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
Huang YK; Huang YL; Hsueh YM; Yang MH; Wu MM; Chen SY; Hsu LI; Chen CJ
Cancer Causes Control; 2008 Oct; 19(8):829-39. PubMed ID: 18351295
[TBL] [Abstract][Full Text] [Related]
5. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235
[TBL] [Abstract][Full Text] [Related]
6. [Effects of arsenic exposure through drinking water on methylation in persons].
Li X; Hou P; Sun G
Wei Sheng Yan Jiu; 2008 Nov; 37(6):657-9. PubMed ID: 19238996
[TBL] [Abstract][Full Text] [Related]
7. Arsenic methylation and bladder cancer risk in Taiwan.
Chen YC; Su HJ; Guo YL; Hsueh YM; Smith TJ; Ryan LM; Lee MS; Christiani DC
Cancer Causes Control; 2003 May; 14(4):303-10. PubMed ID: 12846360
[TBL] [Abstract][Full Text] [Related]
8. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan.
Hsueh YM; Huang YL; Huang CC; Wu WL; Chen HM; Yang MH; Lue LC; Chen CJ
J Toxicol Environ Health A; 1998 Jul; 54(6):431-44. PubMed ID: 9661909
[TBL] [Abstract][Full Text] [Related]
9. Does arsenic exposure increase the risk of development of peripheral vascular diseases in humans?
Yang CY
J Toxicol Environ Health A; 2006 Oct; 69(19):1797-804. PubMed ID: 16905509
[TBL] [Abstract][Full Text] [Related]
10. Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis.
Wu MM; Chiou HY; Hsueh YM; Hong CT; Su CL; Chang SF; Huang WL; Wang HT; Wang YH; Hsieh YC; Chen CJ
Toxicol Appl Pharmacol; 2006 Oct; 216(1):168-75. PubMed ID: 16806340
[TBL] [Abstract][Full Text] [Related]
11. Blackfoot disease and arsenic: a never-ending story.
Tseng CH
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(1):55-74. PubMed ID: 16291522
[TBL] [Abstract][Full Text] [Related]
12. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer.
Hsueh YM; Chiou HY; Huang YL; Wu WL; Huang CC; Yang MH; Lue LC; Chen GS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):589-96. PubMed ID: 9264271
[TBL] [Abstract][Full Text] [Related]
13. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer.
Chen YC; Su HJ; Guo YL; Houseman EA; Christiani DC
Cancer Causes Control; 2005 Mar; 16(2):75-81. PubMed ID: 15868449
[TBL] [Abstract][Full Text] [Related]
14. Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
Urol Int; 2008; 80(4):405-12. PubMed ID: 18587252
[TBL] [Abstract][Full Text] [Related]
15. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
Dopp E; Hartmann LM; Florea AM; von Recklinghausen U; Pieper R; Shokouhi B; Rettenmeier AW; Hirner AV; Obe G
Toxicol Appl Pharmacol; 2004 Dec; 201(2):156-65. PubMed ID: 15541755
[TBL] [Abstract][Full Text] [Related]
16. Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan.
Tseng CH; Chong CK; Chen CJ; Tai TY
Angiology; 1997 Apr; 48(4):321-35. PubMed ID: 9112880
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the sub-chronic toxic effects of three organic arsenical compounds on the urothelium in F344 rats; gender-based differences in response.
Shen J; Wanibuchi H; Waalkes MP; Salim EI; Kinoshita A; Yoshida K; Endo G; Fukushima S
Toxicol Appl Pharmacol; 2006 Feb; 210(3):171-80. PubMed ID: 15950995
[TBL] [Abstract][Full Text] [Related]
18. Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system.
Chang CC; Ho SC; Tsai SS; Yang CY
J Toxicol Environ Health A; 2004 Sep; 67(17):1353-61. PubMed ID: 15371236
[TBL] [Abstract][Full Text] [Related]
19. Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan.
Yang CY; Chiu HF; Chang CC; Ho SC; Wu TN
Environ Res; 2005 May; 98(1):127-32. PubMed ID: 15721893
[TBL] [Abstract][Full Text] [Related]
20. Assessing the human health risks from exposure of inorganic arsenic through oyster (Crassostrea gigas) consumption in Taiwan.
Liu CW; Liang CP; Huang FM; Hsueh YM
Sci Total Environ; 2006 May; 361(1-3):57-66. PubMed ID: 16122780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
